Synthetic fusion protein system for EGFR- and HER2-positive cancers

DISEASE CATEGORY: Cancer

INDICATION: Breast cancer; brain cancer; non-small cell lung cancer (NSCLC); pancreatic cancer

In vitro studies suggest a synthetic fusion protein-based system could

Read the full 237 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE